Status:
UNKNOWN
Genetic Diversity of Toxoplasma Gondii in Cancer Patients
Lead Sponsor:
Sohag University
Conditions:
Toxoplasma Gondii Infection
Cancer
Eligibility:
All Genders
1+ years
Brief Summary
I. Evaluation of T. gondii infection in cancer patients using different serological markers. II. Studying genetic lineages infecting cancer patients in Sohag Governorate to predict clinical course an...
Detailed Description
The global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. Patients with cancer have deficient cellular immunity and are potentially susceptible to o...
Eligibility Criteria
Inclusion
- Hematologic cancers on treatment
- Solid Cancers on treatment
Exclusion
- Patients with other immune compromise states eg. DM, autoimmune diseases
- Patients who are HIV positive
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04834076
Start Date
June 1 2020
End Date
December 1 2022
Last Update
January 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag University Hospitals
Sohag, Egypt